[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "617 463 9385", "website": "https://www.aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors, ovarian, breast, and prostate cancers. The company is also developing ATRN-1051, ATRN-354, and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 55, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 520837, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P. Hamill CPA", "age": 59, "title": "Senior VP, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1964, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dansu  Li Ph.D.", "title": "Head of Technology", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 66, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 61, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1711929600, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.73, "open": 5.6101, "dayLow": 5.61, "dayHigh": 5.6101, "regularMarketPreviousClose": 5.73, "regularMarketOpen": 5.6101, "regularMarketDayLow": 5.61, "regularMarketDayHigh": 5.6101, "forwardPE": -5.8437505, "volume": 862, "regularMarketVolume": 862, "averageVolume": 34140, "averageVolume10days": 6140, "averageDailyVolume10Day": 6140, "marketCap": 30463534, "fiftyTwoWeekLow": 2.78, "fiftyTwoWeekHigh": 8.847, "priceToSalesTrailing12Months": 52.232365, "fiftyDayAverage": 6.50468, "twoHundredDayAverage": 4.73917, "currency": "USD", "enterpriseValue": 10167749, "floatShares": 4188542, "sharesOutstanding": 5430220, "sharesShort": 105828, "sharesShortPriorMonth": 70153, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0195, "heldPercentInsiders": 0.116739996, "heldPercentInstitutions": 0.17695, "shortRatio": 1.49, "shortPercentOfFloat": 0.0219, "impliedSharesOutstanding": 5430220, "bookValue": 4.537, "priceToBook": 1.2364999, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -14286756, "trailingEps": -3.95, "forwardEps": -0.96, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": 17.433, "enterpriseToEbitda": -0.657, "52WeekChange": 0.43112242, "SandP52WeekChange": 0.21231294, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "APRE", "underlyingSymbol": "APRE", "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "firstTradeDateEpochUtc": 1570109400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9a8f76c4-98d0-37f2-b77b-05a35baa6936", "messageBoardId": "finmb_329831339", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.61, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 15.67, "targetMedianPrice": 16.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 21606820, "totalCashPerShare": 3.979, "ebitda": -15464911, "quickRatio": 4.927, "currentRatio": 5.135, "totalRevenue": 583231, "revenuePerShare": 0.161, "returnOnAssets": -0.36625, "returnOnEquity": -0.63189, "freeCashflow": -7674456, "operatingCashflow": -12177608, "operatingMargins": -261.0962, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]